AMEDISYS INC (AMED)

US0234361089 - Common Stock

84.47  +0.69 (+0.82%)

After market: 84.47 0 (0%)

Buy % Consensus

54

ChartMill assigns a Buy % Consensus number of 54% to AMED. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 99.32. This target is 17.58% above the current price.
AMED was analyzed by 16 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about AMED.
In the previous month the buy percentage consensus was at a similar level.
AMED was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 84.4773.73103.0299.32106.05 - -12.71% 21.96% 17.58% 25.55%
Up and Down Grades
Date Firm Action Rating
2024-07-31 Deutsche Bank Downgrade Buy -> Hold
2024-07-25 Cantor Fitzgerald Reiterate Neutral -> Neutral
2024-07-01 William Blair Downgrade Outperform -> Market Perform
2024-04-25 Cantor Fitzgerald Reiterate Neutral -> Neutral
2024-03-26 Raymond James Maintains Market Perform -> Market Perform
2024-03-25 RBC Capital Maintains Outperform -> Outperform
2023-09-14 Cantor Fitzgerald Maintains Neutral -> Neutral
2023-07-31 TD Cowen Maintains Market Perform -> Market Perform
2023-07-27 Credit Suisse Reiterate Neutral -> Neutral
2023-07-06 Jefferies Downgrade Buy -> Hold
2023-06-28 Benchmark Downgrade Buy -> Hold
2023-06-27 Benchmark Downgrade Buy -> Hold
2023-06-27 Truist Securities Maintains Hold -> Hold
2023-06-07 Truist Securities Downgrade Buy -> Hold
2023-06-06 Cantor Fitzgerald Maintains Neutral -> Neutral
2023-06-06 Benchmark Reiterate Buy -> Buy
2023-06-06 Credit Suisse Downgrade Outperform -> Neutral
2023-05-08 TD Cowen Maintains Market Perform
2023-05-05 Barclays Maintains Equal-Weight
2023-05-04 Stephens & Co. Reiterate Equal-Weight
2023-05-04 Truist Securities Maintains Buy
2023-04-21 Cantor Fitzgerald Initiate Neutral
2023-04-13 Truist Securities Maintains Buy
2023-03-14 Benchmark Reiterate Buy
2023-03-14 Stephens & Co. Reiterate Equal-Weight
2023-03-13 Barclays Initiate Equal-Weight
2023-02-27 Credit Suisse Reiterate Outperform
2023-02-21 RBC Capital Maintains Outperform
2023-02-16 Benchmark Maintains Buy
2023-02-16 Stephens & Co. Reiterate Equal-Weight